PDMR shareholding
Bodycote plc (the `Company') announces that on 21 May 2013 it was notified that
the following Directors and Persons Discharging Managerial Responsibilities had
completed the sale of ordinary shares of 17 3/11p in the Company.
Name Shares Price per Total number of % of issued
share beneficial share capital
sold shares held
S Harris 200,000 £5.465 570,030 0.26%
D Landless 5,800 £5.465 494,607 0.30%
The Company was also notified that later on 21 May 2013 the following Director*
and Person Discharging Managerial Responsibilities
`PDMRs', had exercised share options over ordinary shares of 17 3/11 p each in
the Company ("Ordinary Shares"), under the 2010 Co-Investment Plan at an
exercise price of £5.545 per share.
PDMRs Share options Shares sold Shareholding % of issued
exercised under after exercise share
the 2010 capital
Co-Investment Plan
David Landless 8,010 2,072 500,545 0.26%
The announcement is made in accordance with the requirements of DTR 3.1.4
Contact for queries:
Ute Ball, Company Secretary: Springwood Court, Macclesfield, SK10 2XF Tel:
01625 505300
END
*A Private Investor is a recipient of the information who meets all of the conditions set out below, the recipient:
Obtains access to the information in a personal capacity;
Is not required to be regulated or supervised by a body concerned with the regulation or supervision of investment or financial services;
Is not currently registered or qualified as a professional securities trader or investment adviser with any national or state exchange, regulatory authority, professional association or recognised professional body;
Does not currently act in any capacity as an investment adviser, whether or not they have at some time been qualified to do so;
Uses the information solely in relation to the management of their personal funds and not as a trader to the public or for the investment of corporate funds;
Does not distribute, republish or otherwise provide any information or derived works to any third party in any manner or use or process information or derived works for any commercial purposes.
Please note, this site uses cookies. Some of the cookies are essential for parts of the site to operate and have already been set. You may delete and block all cookies from this site, but if you do, parts of the site may not work. To find out more about the cookies used on Investegate and how you can manage them, see our Privacy and Cookie Policy
To continue using Investegate, please confirm that you are a private investor as well as agreeing to our Privacy and Cookie Policy & Terms.